Non-GLP Acute Toxicology Market, Global Outlook and Forecast 2022-2028
Non-GLP studies do not require all of the rigor of GLP studies. Although GLP is written into the Official Register of the United States, compliance with GLP is not required for in vitro drug metabolism and drug interaction studies.
This report contains market size and forecasts of Non-GLP Acute Toxicology in Global, including the following market information:
Global Non-GLP Acute Toxicology Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Non-GLP Acute Toxicology market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Acute Toxicity Testing Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Non-GLP Acute Toxicology include HSRL, Charles River, IITRI, CARE Research, MediTox sro, VivoPharm, Celerion and Bienta, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Non-GLP Acute Toxicology companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Non-GLP Acute Toxicology Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Non-GLP Acute Toxicology Market Segment Percentages, by Type, 2021 (%)
Global Non-GLP Acute Toxicology Market Segment Percentages, by Application, 2021 (%)
Global Non-GLP Acute Toxicology Market Segment Percentages, By Region and Country, 2021 (%)
The report also provides analysis of leading market participants including:
Key companies Non-GLP Acute Toxicology revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Non-GLP Acute Toxicology revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
This report contains market size and forecasts of Non-GLP Acute Toxicology in Global, including the following market information:
Global Non-GLP Acute Toxicology Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Non-GLP Acute Toxicology market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Acute Toxicity Testing Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Non-GLP Acute Toxicology include HSRL, Charles River, IITRI, CARE Research, MediTox sro, VivoPharm, Celerion and Bienta, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Non-GLP Acute Toxicology companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Non-GLP Acute Toxicology Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Non-GLP Acute Toxicology Market Segment Percentages, by Type, 2021 (%)
- Acute Toxicity Testing
- In vitro Cytotoxicity Testing
- Genotoxicity Testing
Global Non-GLP Acute Toxicology Market Segment Percentages, by Application, 2021 (%)
- Rodents
- Canine
- Rabbit
- Others
Global Non-GLP Acute Toxicology Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
The report also provides analysis of leading market participants including:
Key companies Non-GLP Acute Toxicology revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Non-GLP Acute Toxicology revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- HSRL
- Charles River
- IITRI
- CARE Research
- MediTox sro
- VivoPharm
- Celerion
- Bienta
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS
1.1 Non-GLP Acute Toxicology Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Non-GLP Acute Toxicology Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL NON-GLP ACUTE TOXICOLOGY OVERALL MARKET SIZE
2.1 Global Non-GLP Acute Toxicology Market Size: 2021 VS 2028
2.2 Global Non-GLP Acute Toxicology Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 COMPANY LANDSCAPE
3.1 Top Non-GLP Acute Toxicology Players in Global Market
3.2 Top Global Non-GLP Acute Toxicology Companies Ranked by Revenue
3.3 Global Non-GLP Acute Toxicology Revenue by Companies
3.4 Top 3 and Top 5 Non-GLP Acute Toxicology Companies in Global Market, by Revenue in 2021
3.5 Global Companies Non-GLP Acute Toxicology Product Type
3.6 Tier 1, Tier 2 and Tier 3 Non-GLP Acute Toxicology Players in Global Market
3.6.1 List of Global Tier 1 Non-GLP Acute Toxicology Companies
3.6.2 List of Global Tier 2 and Tier 3 Non-GLP Acute Toxicology Companies
4 MARKET SIGHTS BY PRODUCT
4.1 Overview
4.1.1 by Type - Global Non-GLP Acute Toxicology Market Size Markets, 2021 & 2028
4.1.2 Acute Toxicity Testing
4.1.3 In vitro Cytotoxicity Testing
4.1.4 Genotoxicity Testing
4.2 By Type - Global Non-GLP Acute Toxicology Revenue & Forecasts
4.2.1 By Type - Global Non-GLP Acute Toxicology Revenue, 2017-2022
4.2.2 By Type - Global Non-GLP Acute Toxicology Revenue, 2023-2028
4.2.3 By Type - Global Non-GLP Acute Toxicology Revenue Market Share, 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Non-GLP Acute Toxicology Market Size, 2021 & 2028
5.1.2 Rodents
5.1.3 Canine
5.1.4 Rabbit
5.1.5 Others
5.2 By Application - Global Non-GLP Acute Toxicology Revenue & Forecasts
5.2.1 By Application - Global Non-GLP Acute Toxicology Revenue, 2017-2022
5.2.2 By Application - Global Non-GLP Acute Toxicology Revenue, 2023-2028
5.2.3 By Application - Global Non-GLP Acute Toxicology Revenue Market Share, 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Non-GLP Acute Toxicology Market Size, 2021 & 2028
6.2 By Region - Global Non-GLP Acute Toxicology Revenue & Forecasts
6.2.1 By Region - Global Non-GLP Acute Toxicology Revenue, 2017-2022
6.2.2 By Region - Global Non-GLP Acute Toxicology Revenue, 2023-2028
6.2.3 By Region - Global Non-GLP Acute Toxicology Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Non-GLP Acute Toxicology Revenue, 2017-2028
6.3.2 US Non-GLP Acute Toxicology Market Size, 2017-2028
6.3.3 Canada Non-GLP Acute Toxicology Market Size, 2017-2028
6.3.4 Mexico Non-GLP Acute Toxicology Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Non-GLP Acute Toxicology Revenue, 2017-2028
6.4.2 Germany Non-GLP Acute Toxicology Market Size, 2017-2028
6.4.3 France Non-GLP Acute Toxicology Market Size, 2017-2028
6.4.4 U.K. Non-GLP Acute Toxicology Market Size, 2017-2028
6.4.5 Italy Non-GLP Acute Toxicology Market Size, 2017-2028
6.4.6 Russia Non-GLP Acute Toxicology Market Size, 2017-2028
6.4.7 Nordic Countries Non-GLP Acute Toxicology Market Size, 2017-2028
6.4.8 Benelux Non-GLP Acute Toxicology Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Non-GLP Acute Toxicology Revenue, 2017-2028
6.5.2 China Non-GLP Acute Toxicology Market Size, 2017-2028
6.5.3 Japan Non-GLP Acute Toxicology Market Size, 2017-2028
6.5.4 South Korea Non-GLP Acute Toxicology Market Size, 2017-2028
6.5.5 Southeast Asia Non-GLP Acute Toxicology Market Size, 2017-2028
6.5.6 India Non-GLP Acute Toxicology Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Non-GLP Acute Toxicology Revenue, 2017-2028
6.6.2 Brazil Non-GLP Acute Toxicology Market Size, 2017-2028
6.6.3 Argentina Non-GLP Acute Toxicology Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Non-GLP Acute Toxicology Revenue, 2017-2028
6.7.2 Turkey Non-GLP Acute Toxicology Market Size, 2017-2028
6.7.3 Israel Non-GLP Acute Toxicology Market Size, 2017-2028
6.7.4 Saudi Arabia Non-GLP Acute Toxicology Market Size, 2017-2028
6.7.5 UAE Non-GLP Acute Toxicology Market Size, 2017-2028
7 PLAYERS PROFILES
7.1 HSRL
7.1.1 HSRL Corporate Summary
7.1.2 HSRL Business Overview
7.1.3 HSRL Non-GLP Acute Toxicology Major Product Offerings
7.1.4 HSRL Non-GLP Acute Toxicology Revenue in Global Market (2017-2022)
7.1.5 HSRL Key News
7.2 Charles River
7.2.1 Charles River Corporate Summary
7.2.2 Charles River Business Overview
7.2.3 Charles River Non-GLP Acute Toxicology Major Product Offerings
7.2.4 Charles River Non-GLP Acute Toxicology Revenue in Global Market (2017-2022)
7.2.5 Charles River Key News
7.3 IITRI
7.3.1 IITRI Corporate Summary
7.3.2 IITRI Business Overview
7.3.3 IITRI Non-GLP Acute Toxicology Major Product Offerings
7.3.4 IITRI Non-GLP Acute Toxicology Revenue in Global Market (2017-2022)
7.3.5 IITRI Key News
7.4 CARE Research
7.4.1 CARE Research Corporate Summary
7.4.2 CARE Research Business Overview
7.4.3 CARE Research Non-GLP Acute Toxicology Major Product Offerings
7.4.4 CARE Research Non-GLP Acute Toxicology Revenue in Global Market (2017-2022)
7.4.5 CARE Research Key News
7.5 MediTox sro
7.5.1 MediTox sro Corporate Summary
7.5.2 MediTox sro Business Overview
7.5.3 MediTox sro Non-GLP Acute Toxicology Major Product Offerings
7.5.4 MediTox sro Non-GLP Acute Toxicology Revenue in Global Market (2017-2022)
7.5.5 MediTox sro Key News
7.6 VivoPharm
7.6.1 VivoPharm Corporate Summary
7.6.2 VivoPharm Business Overview
7.6.3 VivoPharm Non-GLP Acute Toxicology Major Product Offerings
7.6.4 VivoPharm Non-GLP Acute Toxicology Revenue in Global Market (2017-2022)
7.6.5 VivoPharm Key News
7.7 Celerion
7.7.1 Celerion Corporate Summary
7.7.2 Celerion Business Overview
7.7.3 Celerion Non-GLP Acute Toxicology Major Product Offerings
7.7.4 Celerion Non-GLP Acute Toxicology Revenue in Global Market (2017-2022)
7.7.5 Celerion Key News
7.8 Bienta
7.8.1 Bienta Corporate Summary
7.8.2 Bienta Business Overview
7.8.3 Bienta Non-GLP Acute Toxicology Major Product Offerings
7.8.4 Bienta Non-GLP Acute Toxicology Revenue in Global Market (2017-2022)
7.8.5 Bienta Key News
8 CONCLUSION
9 APPENDIX
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
1.1 Non-GLP Acute Toxicology Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Non-GLP Acute Toxicology Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL NON-GLP ACUTE TOXICOLOGY OVERALL MARKET SIZE
2.1 Global Non-GLP Acute Toxicology Market Size: 2021 VS 2028
2.2 Global Non-GLP Acute Toxicology Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 COMPANY LANDSCAPE
3.1 Top Non-GLP Acute Toxicology Players in Global Market
3.2 Top Global Non-GLP Acute Toxicology Companies Ranked by Revenue
3.3 Global Non-GLP Acute Toxicology Revenue by Companies
3.4 Top 3 and Top 5 Non-GLP Acute Toxicology Companies in Global Market, by Revenue in 2021
3.5 Global Companies Non-GLP Acute Toxicology Product Type
3.6 Tier 1, Tier 2 and Tier 3 Non-GLP Acute Toxicology Players in Global Market
3.6.1 List of Global Tier 1 Non-GLP Acute Toxicology Companies
3.6.2 List of Global Tier 2 and Tier 3 Non-GLP Acute Toxicology Companies
4 MARKET SIGHTS BY PRODUCT
4.1 Overview
4.1.1 by Type - Global Non-GLP Acute Toxicology Market Size Markets, 2021 & 2028
4.1.2 Acute Toxicity Testing
4.1.3 In vitro Cytotoxicity Testing
4.1.4 Genotoxicity Testing
4.2 By Type - Global Non-GLP Acute Toxicology Revenue & Forecasts
4.2.1 By Type - Global Non-GLP Acute Toxicology Revenue, 2017-2022
4.2.2 By Type - Global Non-GLP Acute Toxicology Revenue, 2023-2028
4.2.3 By Type - Global Non-GLP Acute Toxicology Revenue Market Share, 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Non-GLP Acute Toxicology Market Size, 2021 & 2028
5.1.2 Rodents
5.1.3 Canine
5.1.4 Rabbit
5.1.5 Others
5.2 By Application - Global Non-GLP Acute Toxicology Revenue & Forecasts
5.2.1 By Application - Global Non-GLP Acute Toxicology Revenue, 2017-2022
5.2.2 By Application - Global Non-GLP Acute Toxicology Revenue, 2023-2028
5.2.3 By Application - Global Non-GLP Acute Toxicology Revenue Market Share, 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Non-GLP Acute Toxicology Market Size, 2021 & 2028
6.2 By Region - Global Non-GLP Acute Toxicology Revenue & Forecasts
6.2.1 By Region - Global Non-GLP Acute Toxicology Revenue, 2017-2022
6.2.2 By Region - Global Non-GLP Acute Toxicology Revenue, 2023-2028
6.2.3 By Region - Global Non-GLP Acute Toxicology Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Non-GLP Acute Toxicology Revenue, 2017-2028
6.3.2 US Non-GLP Acute Toxicology Market Size, 2017-2028
6.3.3 Canada Non-GLP Acute Toxicology Market Size, 2017-2028
6.3.4 Mexico Non-GLP Acute Toxicology Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Non-GLP Acute Toxicology Revenue, 2017-2028
6.4.2 Germany Non-GLP Acute Toxicology Market Size, 2017-2028
6.4.3 France Non-GLP Acute Toxicology Market Size, 2017-2028
6.4.4 U.K. Non-GLP Acute Toxicology Market Size, 2017-2028
6.4.5 Italy Non-GLP Acute Toxicology Market Size, 2017-2028
6.4.6 Russia Non-GLP Acute Toxicology Market Size, 2017-2028
6.4.7 Nordic Countries Non-GLP Acute Toxicology Market Size, 2017-2028
6.4.8 Benelux Non-GLP Acute Toxicology Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Non-GLP Acute Toxicology Revenue, 2017-2028
6.5.2 China Non-GLP Acute Toxicology Market Size, 2017-2028
6.5.3 Japan Non-GLP Acute Toxicology Market Size, 2017-2028
6.5.4 South Korea Non-GLP Acute Toxicology Market Size, 2017-2028
6.5.5 Southeast Asia Non-GLP Acute Toxicology Market Size, 2017-2028
6.5.6 India Non-GLP Acute Toxicology Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Non-GLP Acute Toxicology Revenue, 2017-2028
6.6.2 Brazil Non-GLP Acute Toxicology Market Size, 2017-2028
6.6.3 Argentina Non-GLP Acute Toxicology Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Non-GLP Acute Toxicology Revenue, 2017-2028
6.7.2 Turkey Non-GLP Acute Toxicology Market Size, 2017-2028
6.7.3 Israel Non-GLP Acute Toxicology Market Size, 2017-2028
6.7.4 Saudi Arabia Non-GLP Acute Toxicology Market Size, 2017-2028
6.7.5 UAE Non-GLP Acute Toxicology Market Size, 2017-2028
7 PLAYERS PROFILES
7.1 HSRL
7.1.1 HSRL Corporate Summary
7.1.2 HSRL Business Overview
7.1.3 HSRL Non-GLP Acute Toxicology Major Product Offerings
7.1.4 HSRL Non-GLP Acute Toxicology Revenue in Global Market (2017-2022)
7.1.5 HSRL Key News
7.2 Charles River
7.2.1 Charles River Corporate Summary
7.2.2 Charles River Business Overview
7.2.3 Charles River Non-GLP Acute Toxicology Major Product Offerings
7.2.4 Charles River Non-GLP Acute Toxicology Revenue in Global Market (2017-2022)
7.2.5 Charles River Key News
7.3 IITRI
7.3.1 IITRI Corporate Summary
7.3.2 IITRI Business Overview
7.3.3 IITRI Non-GLP Acute Toxicology Major Product Offerings
7.3.4 IITRI Non-GLP Acute Toxicology Revenue in Global Market (2017-2022)
7.3.5 IITRI Key News
7.4 CARE Research
7.4.1 CARE Research Corporate Summary
7.4.2 CARE Research Business Overview
7.4.3 CARE Research Non-GLP Acute Toxicology Major Product Offerings
7.4.4 CARE Research Non-GLP Acute Toxicology Revenue in Global Market (2017-2022)
7.4.5 CARE Research Key News
7.5 MediTox sro
7.5.1 MediTox sro Corporate Summary
7.5.2 MediTox sro Business Overview
7.5.3 MediTox sro Non-GLP Acute Toxicology Major Product Offerings
7.5.4 MediTox sro Non-GLP Acute Toxicology Revenue in Global Market (2017-2022)
7.5.5 MediTox sro Key News
7.6 VivoPharm
7.6.1 VivoPharm Corporate Summary
7.6.2 VivoPharm Business Overview
7.6.3 VivoPharm Non-GLP Acute Toxicology Major Product Offerings
7.6.4 VivoPharm Non-GLP Acute Toxicology Revenue in Global Market (2017-2022)
7.6.5 VivoPharm Key News
7.7 Celerion
7.7.1 Celerion Corporate Summary
7.7.2 Celerion Business Overview
7.7.3 Celerion Non-GLP Acute Toxicology Major Product Offerings
7.7.4 Celerion Non-GLP Acute Toxicology Revenue in Global Market (2017-2022)
7.7.5 Celerion Key News
7.8 Bienta
7.8.1 Bienta Corporate Summary
7.8.2 Bienta Business Overview
7.8.3 Bienta Non-GLP Acute Toxicology Major Product Offerings
7.8.4 Bienta Non-GLP Acute Toxicology Revenue in Global Market (2017-2022)
7.8.5 Bienta Key News
8 CONCLUSION
9 APPENDIX
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES
Table 1. Non-GLP Acute Toxicology Market Opportunities & Trends in Global Market
Table 2. Non-GLP Acute Toxicology Market Drivers in Global Market
Table 3. Non-GLP Acute Toxicology Market Restraints in Global Market
Table 4. Key Players of Non-GLP Acute Toxicology in Global Market
Table 5. Top Non-GLP Acute Toxicology Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Non-GLP Acute Toxicology Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Non-GLP Acute Toxicology Revenue Share by Companies, 2017-2022
Table 8. Global Companies Non-GLP Acute Toxicology Product Type
Table 9. List of Global Tier 1 Non-GLP Acute Toxicology Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Non-GLP Acute Toxicology Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Non-GLP Acute Toxicology Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Non-GLP Acute Toxicology Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Non-GLP Acute Toxicology Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Non-GLP Acute Toxicology Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Non-GLP Acute Toxicology Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Non-GLP Acute Toxicology Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Non-GLP Acute Toxicology Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Non-GLP Acute Toxicology Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Non-GLP Acute Toxicology Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Non-GLP Acute Toxicology Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Non-GLP Acute Toxicology Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Non-GLP Acute Toxicology Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Non-GLP Acute Toxicology Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Non-GLP Acute Toxicology Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Non-GLP Acute Toxicology Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Non-GLP Acute Toxicology Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Non-GLP Acute Toxicology Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Non-GLP Acute Toxicology Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Non-GLP Acute Toxicology Revenue, (US$, Mn), 2023-2028
Table 30. HSRL Corporate Summary
Table 31. HSRL Non-GLP Acute Toxicology Product Offerings
Table 32. HSRL Non-GLP Acute Toxicology Revenue (US$, Mn), (2017-2022)
Table 33. Charles River Corporate Summary
Table 34. Charles River Non-GLP Acute Toxicology Product Offerings
Table 35. Charles River Non-GLP Acute Toxicology Revenue (US$, Mn), (2017-2022)
Table 36. IITRI Corporate Summary
Table 37. IITRI Non-GLP Acute Toxicology Product Offerings
Table 38. IITRI Non-GLP Acute Toxicology Revenue (US$, Mn), (2017-2022)
Table 39. CARE Research Corporate Summary
Table 40. CARE Research Non-GLP Acute Toxicology Product Offerings
Table 41. CARE Research Non-GLP Acute Toxicology Revenue (US$, Mn), (2017-2022)
Table 42. MediTox sro Corporate Summary
Table 43. MediTox sro Non-GLP Acute Toxicology Product Offerings
Table 44. MediTox sro Non-GLP Acute Toxicology Revenue (US$, Mn), (2017-2022)
Table 45. VivoPharm Corporate Summary
Table 46. VivoPharm Non-GLP Acute Toxicology Product Offerings
Table 47. VivoPharm Non-GLP Acute Toxicology Revenue (US$, Mn), (2017-2022)
Table 48. Celerion Corporate Summary
Table 49. Celerion Non-GLP Acute Toxicology Product Offerings
Table 50. Celerion Non-GLP Acute Toxicology Revenue (US$, Mn), (2017-2022)
Table 51. Bienta Corporate Summary
Table 52. Bienta Non-GLP Acute Toxicology Product Offerings
Table 53. Bienta Non-GLP Acute Toxicology Revenue (US$, Mn), (2017-2022)
Table 1. Non-GLP Acute Toxicology Market Opportunities & Trends in Global Market
Table 2. Non-GLP Acute Toxicology Market Drivers in Global Market
Table 3. Non-GLP Acute Toxicology Market Restraints in Global Market
Table 4. Key Players of Non-GLP Acute Toxicology in Global Market
Table 5. Top Non-GLP Acute Toxicology Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Non-GLP Acute Toxicology Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Non-GLP Acute Toxicology Revenue Share by Companies, 2017-2022
Table 8. Global Companies Non-GLP Acute Toxicology Product Type
Table 9. List of Global Tier 1 Non-GLP Acute Toxicology Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Non-GLP Acute Toxicology Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Non-GLP Acute Toxicology Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Non-GLP Acute Toxicology Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Non-GLP Acute Toxicology Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Non-GLP Acute Toxicology Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Non-GLP Acute Toxicology Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Non-GLP Acute Toxicology Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Non-GLP Acute Toxicology Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Non-GLP Acute Toxicology Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Non-GLP Acute Toxicology Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Non-GLP Acute Toxicology Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Non-GLP Acute Toxicology Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Non-GLP Acute Toxicology Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Non-GLP Acute Toxicology Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Non-GLP Acute Toxicology Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Non-GLP Acute Toxicology Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Non-GLP Acute Toxicology Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Non-GLP Acute Toxicology Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Non-GLP Acute Toxicology Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Non-GLP Acute Toxicology Revenue, (US$, Mn), 2023-2028
Table 30. HSRL Corporate Summary
Table 31. HSRL Non-GLP Acute Toxicology Product Offerings
Table 32. HSRL Non-GLP Acute Toxicology Revenue (US$, Mn), (2017-2022)
Table 33. Charles River Corporate Summary
Table 34. Charles River Non-GLP Acute Toxicology Product Offerings
Table 35. Charles River Non-GLP Acute Toxicology Revenue (US$, Mn), (2017-2022)
Table 36. IITRI Corporate Summary
Table 37. IITRI Non-GLP Acute Toxicology Product Offerings
Table 38. IITRI Non-GLP Acute Toxicology Revenue (US$, Mn), (2017-2022)
Table 39. CARE Research Corporate Summary
Table 40. CARE Research Non-GLP Acute Toxicology Product Offerings
Table 41. CARE Research Non-GLP Acute Toxicology Revenue (US$, Mn), (2017-2022)
Table 42. MediTox sro Corporate Summary
Table 43. MediTox sro Non-GLP Acute Toxicology Product Offerings
Table 44. MediTox sro Non-GLP Acute Toxicology Revenue (US$, Mn), (2017-2022)
Table 45. VivoPharm Corporate Summary
Table 46. VivoPharm Non-GLP Acute Toxicology Product Offerings
Table 47. VivoPharm Non-GLP Acute Toxicology Revenue (US$, Mn), (2017-2022)
Table 48. Celerion Corporate Summary
Table 49. Celerion Non-GLP Acute Toxicology Product Offerings
Table 50. Celerion Non-GLP Acute Toxicology Revenue (US$, Mn), (2017-2022)
Table 51. Bienta Corporate Summary
Table 52. Bienta Non-GLP Acute Toxicology Product Offerings
Table 53. Bienta Non-GLP Acute Toxicology Revenue (US$, Mn), (2017-2022)
LIST OF FIGURES
Figure 1. Non-GLP Acute Toxicology Segment by Type in 2021
Figure 2. Non-GLP Acute Toxicology Segment by Application in 2021
Figure 3. Global Non-GLP Acute Toxicology Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Non-GLP Acute Toxicology Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Non-GLP Acute Toxicology Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Non-GLP Acute Toxicology Revenue in 2021
Figure 8. By Type - Global Non-GLP Acute Toxicology Revenue Market Share, 2017-2028
Figure 9. By Application - Global Non-GLP Acute Toxicology Revenue Market Share, 2017-2028
Figure 10. By Region - Global Non-GLP Acute Toxicology Revenue Market Share, 2017-2028
Figure 11. By Country - North America Non-GLP Acute Toxicology Revenue Market Share, 2017-2028
Figure 12. US Non-GLP Acute Toxicology Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Non-GLP Acute Toxicology Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Non-GLP Acute Toxicology Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Non-GLP Acute Toxicology Revenue Market Share, 2017-2028
Figure 16. Germany Non-GLP Acute Toxicology Revenue, (US$, Mn), 2017-2028
Figure 17. France Non-GLP Acute Toxicology Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Non-GLP Acute Toxicology Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Non-GLP Acute Toxicology Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Non-GLP Acute Toxicology Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Non-GLP Acute Toxicology Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Non-GLP Acute Toxicology Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Non-GLP Acute Toxicology Revenue Market Share, 2017-2028
Figure 24. China Non-GLP Acute Toxicology Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Non-GLP Acute Toxicology Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Non-GLP Acute Toxicology Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Non-GLP Acute Toxicology Revenue, (US$, Mn), 2017-2028
Figure 28. India Non-GLP Acute Toxicology Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Non-GLP Acute Toxicology Revenue Market Share, 2017-2028
Figure 30. Brazil Non-GLP Acute Toxicology Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Non-GLP Acute Toxicology Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Non-GLP Acute Toxicology Revenue Market Share, 2017-2028
Figure 33. Turkey Non-GLP Acute Toxicology Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Non-GLP Acute Toxicology Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Non-GLP Acute Toxicology Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Non-GLP Acute Toxicology Revenue, (US$, Mn), 2017-2028
Figure 37. HSRL Non-GLP Acute Toxicology Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Charles River Non-GLP Acute Toxicology Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. IITRI Non-GLP Acute Toxicology Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. CARE Research Non-GLP Acute Toxicology Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. MediTox sro Non-GLP Acute Toxicology Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. VivoPharm Non-GLP Acute Toxicology Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Celerion Non-GLP Acute Toxicology Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Bienta Non-GLP Acute Toxicology Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 1. Non-GLP Acute Toxicology Segment by Type in 2021
Figure 2. Non-GLP Acute Toxicology Segment by Application in 2021
Figure 3. Global Non-GLP Acute Toxicology Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Non-GLP Acute Toxicology Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Non-GLP Acute Toxicology Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Non-GLP Acute Toxicology Revenue in 2021
Figure 8. By Type - Global Non-GLP Acute Toxicology Revenue Market Share, 2017-2028
Figure 9. By Application - Global Non-GLP Acute Toxicology Revenue Market Share, 2017-2028
Figure 10. By Region - Global Non-GLP Acute Toxicology Revenue Market Share, 2017-2028
Figure 11. By Country - North America Non-GLP Acute Toxicology Revenue Market Share, 2017-2028
Figure 12. US Non-GLP Acute Toxicology Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Non-GLP Acute Toxicology Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Non-GLP Acute Toxicology Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Non-GLP Acute Toxicology Revenue Market Share, 2017-2028
Figure 16. Germany Non-GLP Acute Toxicology Revenue, (US$, Mn), 2017-2028
Figure 17. France Non-GLP Acute Toxicology Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Non-GLP Acute Toxicology Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Non-GLP Acute Toxicology Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Non-GLP Acute Toxicology Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Non-GLP Acute Toxicology Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Non-GLP Acute Toxicology Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Non-GLP Acute Toxicology Revenue Market Share, 2017-2028
Figure 24. China Non-GLP Acute Toxicology Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Non-GLP Acute Toxicology Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Non-GLP Acute Toxicology Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Non-GLP Acute Toxicology Revenue, (US$, Mn), 2017-2028
Figure 28. India Non-GLP Acute Toxicology Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Non-GLP Acute Toxicology Revenue Market Share, 2017-2028
Figure 30. Brazil Non-GLP Acute Toxicology Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Non-GLP Acute Toxicology Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Non-GLP Acute Toxicology Revenue Market Share, 2017-2028
Figure 33. Turkey Non-GLP Acute Toxicology Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Non-GLP Acute Toxicology Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Non-GLP Acute Toxicology Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Non-GLP Acute Toxicology Revenue, (US$, Mn), 2017-2028
Figure 37. HSRL Non-GLP Acute Toxicology Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Charles River Non-GLP Acute Toxicology Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. IITRI Non-GLP Acute Toxicology Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. CARE Research Non-GLP Acute Toxicology Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. MediTox sro Non-GLP Acute Toxicology Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. VivoPharm Non-GLP Acute Toxicology Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Celerion Non-GLP Acute Toxicology Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Bienta Non-GLP Acute Toxicology Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
